CIBC World Market
ASND icon

CIBC World Market’s Ascendis Pharma A/S ASND Stock Holding History

CIBC World Market’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46M Buy
6,381
+20
+0.3% +$4.48K ﹤0.01% 828
2025
Q4 		$1.36M Buy
6,361
+193
+3% +$39.9K ﹤0.01% 863
2025
Q3 		$1.23M Buy
+6,168
New +$1.15M ﹤0.01% 885

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIBC World Market's ASND Position: Q1 2026 in Review

CIBC World Market increased its Ascendis Pharma A/S (ASND) stake by 0.31% in Q1 2026, buying an estimated $4.48K and bringing the position to 6,381 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #828.

CIBC World Market first reported a position in ASND in Q3 2025 and has held it in 3 quarters since. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • CIBC World Market held 6,381 shares of Ascendis Pharma A/S worth $1.46M as of Q1 2026.
  • CIBC World Market bought 20 Ascendis Pharma A/S shares in Q1 2026, an estimated $4.48K.
  • Ascendis Pharma A/S made up ﹤0.01% of CIBC World Market's portfolio in Q1 2026, its #828 holding.
  • CIBC World Market first reported a position in Ascendis Pharma A/S in Q3 2025 and has held it in 3 quarters since.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.